NEW YORK (GenomeWeb) – Bruker reported after the close of the market Thursday that its fourth quarter revenues were up 13 percent year over year.

For the three months ended Dec. 31, the company reported revenues of $530.5 million, up from $470.3 million in Q4 2016, and beating the average analyst estimate of $504.0 million.

Organic revenue growth during the quarter was 4 percent, with acquisitions contributing 4 percent and foreign currency translation boosting revenues 5 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.